In this large population based case control study, recent initiation of an inhaled anticholinergic medication increased the odds of acute urinary retention (OR 1.4, CI 1.2-1.7), which was even higher in men with existing BPH (OR 1.8, CI 1.5-2.2). Men using both short and long acting had 3 times the odds of acute retention compared to non-users (OR 2.7, CI 1.9-3.8). New or ongoing inhaled anticholinergics should be considered causative in men with acute urinary retention (abstract)
Share This Post
Categories
Related Posts
While spring 2020 feels like a lifetime ago, COVID-19 is still with us. Unfortunately, this winter has brought more infections, hospitalizations, and death rates that eclipse what many saw last spring. But this time, while the headlines are back about hospitals running low on PPE, ICU bed shortages, and long lines for testing, we now […]
This article is part of a series in The Hospital Leader written by members of the Division of Hospital Medicine at Dell Medical School at The University of Texas in Austin, exploring lessons learned from the coronavirus pandemic and outlining an approach for creating COVID-19 Centers of Excellence. Evidence on emerging treatments for COVID-19 has […]
While all of us see patients who smoke in their 70s or 80s, due to their limited lifespan from COPD, DM, malignancy, etc., and their expressed wishes to continue tobacco, we keep our admonitions to a minimum. We accept our patient has become learned enough through life to make their own decisions and accept whatever […]
Leave A Comment